ARCHIVES

FDA Invites Ad Hoc Consumer Reps To ODAC Meetings

This article is from The Cancer Letter archive.

Vol. 21 No. 07 | February 17, 1995

Download PDF Visit The Full Archive

Related Articles

Schmidt Attempted To Answer Critics

October 1, 1976

ASCO Teleconference Set For Nov. 12

October 31, 1986

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

ASRO President Tells Colleagues To Take Charge

October 26, 1990

CTRC, UCLA Receive Gifts; NCCF Distributes Gold Pins.

March 24, 2000